https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL’s Board of Trustees Approves Annual Accounts and Consolidates Its Growth as a Benchmark in Biomedical Research

7 de July de 2025

The Board of Trustees of the Marqués de Valdecilla Research Institute Foundation (IDIVAL) has approved its annual accounts for the 2024 financial year, confirming the institution’s financial stability and soundness.

The meeting, held at the Government Pavilion of the University of Cantabria, also provided an opportunity to review a year marked by continuous growth in scientific output, the acquisition of competitive research projects, and the development of strategic initiatives in biomedical research and smart health data management in Cantabria.

During the session, the joint report by IDIVAL’s Scientific Director, Marcos López Hoyos, and Managing Director, Galo Peralta, was presented. The report highlighted the increase in research activity and the regional impact of the institute, as well as outlining priority action lines for the coming years.

Among the items addressed, the Board of Trustees authorized the signing of contracts linked to the VALDATA project: Cantabria Towards a Health Data Economy, a strategic initiative that will position the region as a benchmark in this field and reinforces IDIVAL’s commitment to innovation and the improvement of the healthcare system. The Board also approved the expansion of the External Scientific Committee with the addition of researcher Mara Dierssen, and the amendment of the Internal Regulations to adapt the composition of the Internal Council in line with the new accreditation guidelines for Health Research Institutes, recently approved by the Spanish Ministry of Science, Innovation and Universities.

IDIVAL’s Board of Trustees is chaired by the Regional Minister of Health, César Pascual, and includes institutional representation from the Cantabrian Health Service, the Marqués de Valdecilla University Hospital, the University of Cantabria, and professionals from the healthcare and academic sectors.

With the approval of these accounts and the roadmap set for the future, IDIVAL continues to advance its mission of promoting biomedical research and transferring its results into clinical practice, contributing to scientific progress and the well-being of the Cantabrian community.

Further information: https://www.idival.org/organos-de-gobierno/

Photo: University of Cantabria